These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 7502528

  • 1. The consequences of hypergastrinemia.
    Creutzfeldt W.
    Yale J Biol Med; 1994; 67(3-4):181-94. PubMed ID: 7502528
    [Abstract] [Full Text] [Related]

  • 2. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C, D'Adda T, Azzoni C, Pilato FP, Caruana P.
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [Abstract] [Full Text] [Related]

  • 3. Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin.
    Larsson LI, Rehfeld JF, Stockbrügger R, Blohme G, Schöön IM, Lundqvist G, Kindblom LG, Säve-Söderberg J, Grimelius L, Olbe L.
    Am J Pathol; 1978 Oct; 93(1):53-68. PubMed ID: 696807
    [Abstract] [Full Text] [Related]

  • 4. Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach.
    Håkanson R, Böttcher G, Sundler F, Vallgren S.
    Digestion; 1986 Oct; 35 Suppl 1():23-41. PubMed ID: 3539678
    [Abstract] [Full Text] [Related]

  • 5. The pathobiology of the human enterochromaffin-like cell.
    Modlin IM, Nangia AK.
    Yale J Biol Med; 1992 Oct; 65(6):775-92; discussion 827-9. PubMed ID: 1341078
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis.
    Solcia E, Fiocca R, Villani L, Luinetti O, Capella C.
    Am J Surg Pathol; 1995 Oct; 19 Suppl 1():S1-7. PubMed ID: 7762735
    [Abstract] [Full Text] [Related]

  • 8. Clinical aspects of ECL-cell abnormalities.
    Hirschowitz BI.
    Yale J Biol Med; 1998 Oct; 71(3-4):303-10. PubMed ID: 10461361
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of mastomys ECL cell function by transforming growth factor alpha.
    Lawton GP, Tang L, Kidd M, Chinery R, Miu K, Modlin IM.
    J Surg Res; 1996 Feb 01; 60(2):293-302. PubMed ID: 8598657
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathology of endocrine cells in gastric mucosa.
    Bordi C, Ravazzola M, de Vita O.
    Ann Pathol; 1983 Feb 01; 3(1):19-28. PubMed ID: 6838707
    [Abstract] [Full Text] [Related]

  • 15. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
    Lehy T, Roucayrol AM, Mignon M.
    Microsc Res Tech; 2000 Mar 15; 48(6):327-38. PubMed ID: 10738314
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of CCN2/CTGF in the proliferation of Mastomys enterochromaffin-like cells and gastric carcinoid development.
    Kidd M, Modlin IM, Eick GN, Camp RL, Mane SM.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan 15; 292(1):G191-200. PubMed ID: 16950763
    [Abstract] [Full Text] [Related]

  • 19. Gastric carcinoids in patients with hypergastrinemia.
    Jordan PH, Barroso A, Sweeney J.
    J Am Coll Surg; 2004 Oct 15; 199(4):552-5. PubMed ID: 15454137
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.